Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Elos Medtech Interim Report January 1 – June 30, 2023

April – June 2023 · Net sales for the second quarter amounted to SEK 269.8 (233.1) million, an increase of 15.8 percent compared to the same quarter last year. Net sales in local currencies increased by 9.5 percent. · Operating profit amounted to SEK 30.1 (37.8) million, corresponding to an operating margin of 11.2 (16.2) percent. · Profit after net financial items amounted to SEK 13.7 (38.8) million. Net financial items were negatively affected by exchange rate differences of SEK -8.6 (3.6) million and totaled SEK -16.4 (1.1) million. · Cash flow from operating activities was

NYAB Oyj - Managers' Transactions

NYAB PlcMANAGERS' TRANSACTIONS14 July 2023 at 16:00NYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: BINGAB Barents Investment Group ABPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Johan LarssonPosition: Chief Executive OfficerIssuer: NYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 35585/4/4 ____________________________________________Transaction date: 2023-07-11

Publication of a Prospectus

Regulatory Announcement Publication of Prospectus Not for release, publication or distribution, directly or indirectly, in or into the United States. The following prospectus has been approved by the Financial Conduct Listing Authority and, along with the documents incorporated by reference therein, is available for viewing: Notes Base Prospectus dated July 14, 2023 relating to the Programme for the Issuance of Securities of Royal Bank of Canada which was approved by the Financial Conduct Listing Authority on July 14, 2023. The Prospectus, together with the documents

Publishing of Stockmann’s Half-year Financial Report for January–June 2023

STOCKMANN plc, Press release 14.7.2023 at 15:30 EEST Stockmann plc will publish its Half-year Financial Report for January–June 2023 on Friday 21 July 2023 at 8:00 EEST. A press and analyst briefing will be held in English the same day at 10:00 EEST as a live webcast that can be followed by this link . The recording and presentation material will be available on the company's website after the event. Further information:Stockmann Media DeskMon–Fri 9–16 EESTtel. +358 50 389 0011info@stockmann.com www.

Elkem ASA – Mandatory notification of trade – primary insider

Oslo, 14 July 2023 Helge Aasen, CEO in Elkem ASA (OSE ticker code: "ELK"), has on 14 July 2023 purchased 22,200 shares in Elkem ASA at an average price of NOK 22.50 per share. Following this transaction Helge Aasen holds 68,406 shares and 101,000 options in Elkem ASA. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. For further information, please contact: Odd-Geir LyngstadVP Finance & Investor RelationsTel: +47 976 72 806Email: odd-geir.lyngstad@elkem.com About ElkemElkem is one of the world’

Clinical Laserthermia Systems conducts a directed offset issue to underwriters in connection with the completed rights issue of units

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA, BELARUS OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES BEYOND THOSE REQUIRED BY SWEDISH LAW. PLEASE SEE "IMPORTANT INFORMATION" AT THE END OF THIS PRESS RELEASE. Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") has completed the rights issue of units, which

July Gardening Advice - Everything You Need to Do This Month

July is a beautiful month for enjoying the garden. Traditionally the hottest month of the year in the UK, July is all about spending time in the garden and enjoying your outdoor space.   [A pair of scissors on grass Description automatically generated]   When it comes to maintaining the garden, this month is all about keeping on top of your blooms, nurturing your plants, and providing your garden with that extra bit of TLC that it needs to prevent damage or dryness.   Expert gardener Fiona Jenkins at MyJobQuote.co.uk  has a list of top tips

CS MEDICA announces that CANNORDIC India Pvt. Ltd. is Established to Expand Presence in India

CS MEDICA A/S (“CS MEDICA” or the “Company”), a MedTech company specializing in Cannabis and pain management, is thrilled to announce the establishment of CANNORDIC India Pvt. Ltd is final. The Indian subsidiary is located at B-007, Param Tower CHS Ltd, Raghunath Nagar, Survewadi, Thane West-400604.On April 14, 2023, the Company announced that its board of directors approved setting up the subsidiary in India. CANNORDIC India Pvt. Ltd. marks a significant milestone in its expansion strategy, solidifying its commitment to the Indian market and the rest of APAC. With the vision to improve

Learning dentistry with state-of-the-art instruction and technologies

The Faculty of Dentistry at the University of British Columbia (UBC) in Vancouver, Canada, recently upgraded their dental chairs and opened a new simulation laboratory with Planmeca solutions. With state-of-the-art equipment, UBC Dentistry ensures their students will continue to receive the best possible dental education experience over the next decade. The previous dental chairs, also manufactured by Planmeca, were used for almost twenty years, serving as a testament to the reliability, exceptional quality, and timeless design of Planmeca products. The University of British

BioStock: Alligator Bioscience’s CSO presents CD40 portfolio at summit

Alligator Bioscience’s CD40 agonist mitazalimab has recently shown promising results in a second interim analysis of the OPTIMIZE-1 phase II study in pancreatic cancer. The results will be presented by CSO Peter Ellmark at the 3rd Annual Tumour Myeloid-Directed Therapies Summit in Boston. His presentation also features the company’s bispecific CD40/CEACAM5 antibody ATOR-4066 and its potential to induce strong anti-tumour response in patients with CEACAM5-expressing tumours. BioStock contacted Peter Ellmark to get to know more.Read the full article at biostock.se: https://www.biostock.se/

Annual Financial Report

LEI 2138006E2VG89XLORJ06 Publication of Annual Report and Financial Statements Yorkshire Water Services Limited   The audited annual report and financial statements of Yorkshire Water Services Limited for the year ended 31 March 2023 has now been submitted to the National Storage Mechanism and will be shortly available for inspection at http://www.morningstar.co.uk/uk/NSM. The full document can also be found at https://www.yorkshirewater.com/reports   For further information please contact: Yorkshire Water Services Limited Western House Halifax Road Bradford

Half-yearly report, January – June 2023

High growth in recurring revenues and savings program implementedApril - June 2023 · Revenues increased by 4.2 per cent to SEK 1,201.7 million (1,153.7).  · Adjusted EBITA decreased by 0.9 per cent and amounted to SEK 81.4 million (82.1), corresponding to an adjusted EBITA margin of 6.8 per cent (7.1).  · Cost efficiency program implemented with estimated savings amounting to between SEK 45 and 50 million in the current year, which resulted in restructuring costs accounted for as items affecting comparability of SEK 19.6 million. · Profit before tax amounted to SEK 34.4

Half-year report January – June 2023

· Rental income increased 21 per cent to SEK 2,386 million (1 980). · Profit from property management amounted to SEK 1,187 million (1,184). · Changes in the value of properties amounted to SEK -2,954 million (4,500). · Changes in the value of financial instruments amounted to SEK -76 million (68). · Loss after tax for the period amounted to SEK -1,517 million (4,790). · The market value of the properties amounted to SEK 85,071 million (84,683). · During the period, SEK 1,398 million (1,960) was invested in the existing property portfolio. · During the period, 5

Interim Report January—June 2023: New record for order intake, revenue, and profit in a mixed market

Second quarter · Order intake rose by 5 percent to 698 MSEK (667). · Net sales increased by 20 percent to 638 MSEK (533). · EBIT doubled to 85.8 MSEK (40.8). · EBIT margin rose to 13.4 percent (7.7) · Profit after tax increased to 57.9 MSEK (28.1). · Earnings per share rose to 2.00 SEK (0.97). · New order strengthened business entity Westermo’s position with a major Swiss train manufacturer. · The Beijer Electronics business entity acquired the German software company Smart HMI. · Kristine Lindberg took office as CEO of the Beijer Electronics business entity.

Good net sales and profitability in a challenging market

Second quarter: April - June The half-year period: January– June · Net sales amounted to 346MSEK (351) · Net sales increased by · Order intake amounted to 5 percent to 672 MSEK (640)301 MSEK (364) · Order intake amounted · Order backlog amounted to to 547 MSEK (656)1,195 MSEK (1,592) · Adjusted operating · Adjusted operating profit profit (EBITA) improved to(EBITA) improved to 31 MSEK 59 MSEK (56)(29) · Operating profit ·

Spinnova Plc: Managers’ Transactions: Harri Sundvik

SPINNOVA PLC, MANAGERS’ TRANSACTIONS, 14 JULY 2023 AT 2:00 P.M. EEST     Spinnova Plc: Managers’ Transactions: Harri Sundvik   Spinnova Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Harri Sundvik Position: Member of the Board/Deputy member  Issuer: Spinnova Oyj LEI: 7437000SWC9YSSJWZB91 Notification type: INITIAL NOTIFICATION Reference number: 35544/5/4 ____________________________________________ Transaction date: 2023-07-11 Venue: NASDAQ HELSINKI LTD (XHEL)

Spinnova Plc: Managers’ Transactions: Harri Sundvik

SPINNOVA PLC, MANAGERS’ TRANSACTIONS, 14 JULY 2023 AT 2:00 P.M. EEST     Spinnova Plc: Managers’ Transactions: Harri Sundvik Spinnova Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Harri Sundvik Position: Member of the Board/Deputy member  Issuer: Spinnova Oyj LEI: 7437000SWC9YSSJWZB91 Notification type: INITIAL NOTIFICATION Reference number: 35549/5/4 ____________________________________________ Transaction date: 2023-07-13 Venue: NASDAQ HELSINKI LTD (XHEL)

Spinnova Plc: Managers’ Transactions: Harri Sundvik

SPINNOVA PLC, MANAGERS’ TRANSACTIONS, 14 JULY 2023 AT 2:00 P.M. EEST     Spinnova Plc: Managers’ Transactions: Harri Sundvik   Spinnova Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Harri Sundvik Position: Member of the Board/Deputy member Issuer: Spinnova Oyj LEI: 7437000SWC9YSSJWZB91 Notification type: INITIAL NOTIFICATION Reference number: 35547/5/4 ____________________________________________ Transaction date: 2023-07-12 Venue: NASDAQ HELSINKI LTD (XHEL)

Rikshem's half-year report January - June 2023: High demand in a challenging property market

Rikshem increased its rental income by 8.6 percent. Net operating income was MSEK 920 (867), up 6.2 percent. Property investments in the period totaled MSEK 1,052 (1,249). At the end of the period, Moody's reaffirmed Rikshem's credit rating of A3 with stable outlook- Financing costs are now rising faster than both revenues and other expenses, leading to a decrease in operating income. However, our interest rate duration and debt duration remain reassuring, which means it will take time before higher interest rates fully take effect. Higher financing costs mean that we are postponing the

Invitation to LeadDesk’s January–June 2023 results briefing

LeadDesk Plc Press Release 14 July 2023 13.05 EETInvitation to LeadDesk’s January–June 2023 results briefing LeadDesk will publish its 1.1.-30.6.2023 financial statements bulletin on Monday 7 August 2023 at approximately 9 am EET (10.00 CET). The company is organizing a results briefing for analysts, the media, and investors on 7 August 2023 at 11.00 EET Finnish time (10.00 CET). LeadDesk’s CEO, Olli Nokso-Koivisto and CFO, Kaisa Rönkkö will present the financial results for H1 2023 and outlook for the autumn followed by a fireside chat hosted by Henri Palomäki from Sijoittaja.fi.

Invitation to telephone conference regarding Skanska’s Interim report second quarter on July 21

Skanska’s Interim report second quarter 2023 will be released on Friday, July 21 at 07:30 am CET. The report will be presented by Anders Danielsson, Skanska’s President and CEO, and Magnus Persson, CFO, at a telephone conference at 10:00 am CEST. The telephone conference will be webcasted live at www.skanska.com/investors, where it also will be posted shortly afterwards. To participate in the telephone conference, with the possibility to ask questions, please dial +46 (0)8 5051 0031; +44 (0) 207 107 06 13, or +1 (1) 631 570 56 13. After the telephone conference, there will be

Interim report för Duni AB (publ) January 1 - June 30, 2023

Improved margins in strong quarter April 1 – June 30 · Net sales amounted to SEK 1,936 m (1,724), corresponding to a 12.3% increase in sales. At fixed exchange rates, this corresponds to a 5.6% increase. · The gross profit amounted to SEK 440 m (283), an increase of 55% in absolute terms compared with the same period last year. The gross margin increased by 6 percentage points. · Operating income amounted to SEK 170 m (91), corresponding to an increase of 87.1% compared with the same period last year. · The quarter showed a strong cash flow with a reduced net debt.  [

Interim report Rejlers AB January – June 2023

April – June   · Net sales increased by 18.2 per cent to SEK 1,058.2 million (895.3) · Organic sales amounted to 5.2 per cent (7.8) · EBITA increased to SEK 70.5 million (64.3), and the EBITA margin was 6.7 per cent (7.2), impacted by one working day less than in the previous year · Operating profit (EBIT) increased to SEK 55.1 million (51.9), impacted by acquisition expenses of SEK 0.1 million (0.3), with regard to the acquisition of Eurocon · Net profit after tax increased to SEK 47.2 million (41.2) · Earnings per share before dilution amounted to SEK 2.14 (2.04) and

Why Securities Need to Be on the Blockchain?

MyntExchange is born out of need.One of the fundamental benefits of blockchain technology is its ability to record transactions transparently in a tamper-proof ledger. This level of openness is unprecedented in a financial sector where obscurity, complicated acronyms, and manipulation benefit only the most powerful players. Specifically, blockchain technology can shine a light on unethical tactics like the use of dark pools—private exchanges where large trades happen, hidden from the public eye. In short, these pools allow hedge funds to influence prices undetected by dumping stocks en

There are no items matching the current filter
There are no more items matching the current filter
Back to top